Subbu Nambi
Stock Analyst at Guggenheim
(4.71)
# 158
Out of 5,111 analysts
53
Total ratings
67.44%
Success rate
24.28%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.74 | - | 4 | Nov 21, 2025 | |
| GRAL GRAIL | Upgrades: Buy | $100 | $91.04 | +9.84% | 2 | Nov 12, 2025 | |
| PSNL Personalis | Maintains: Buy | $6 → $12 | $8.48 | +41.51% | 1 | Nov 11, 2025 | |
| VCYT Veracyte | Maintains: Buy | $40 → $45 | $43.53 | +3.38% | 4 | Nov 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $115 → $170 | $150.61 | +12.87% | 2 | Oct 29, 2025 | |
| RVTY Revvity | Initiates: Neutral | n/a | $99.08 | - | 1 | Oct 16, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $20 | $15.69 | +27.47% | 1 | Sep 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $80 → $95 | $68.67 | +38.34% | 4 | Sep 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $67 | $102.67 | -34.74% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $26.70 | +34.83% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $228.53 | +9.39% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $6.85 | +45.99% | 3 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $114 | $134.92 | -15.51% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $31.07 | +60.93% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $9.24 | +8.23% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.99 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $45.67 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $228.40 | -12.43% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.72 | +27.12% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.90 | +215.79% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.76 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $160.58 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $38.88 | -35.70% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.12 | - | 1 | Dec 14, 2023 |
Exact Sciences
Nov 21, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.74
Upside: -
GRAIL
Nov 12, 2025
Upgrades: Buy
Price Target: $100
Current: $91.04
Upside: +9.84%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $6 → $12
Current: $8.48
Upside: +41.51%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $43.53
Upside: +3.38%
GeneDx Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $115 → $170
Current: $150.61
Upside: +12.87%
Revvity
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $99.08
Upside: -
Adaptive Biotechnologies
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $15.69
Upside: +27.47%
Tempus AI
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $68.67
Upside: +38.34%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $102.67
Upside: -34.74%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $26.70
Upside: +34.83%
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $228.53
Upside: +9.39%
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $6.85
Upside: +45.99%
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $134.92
Upside: -15.51%
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $31.07
Upside: +60.93%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.24
Upside: +8.23%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.99
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $45.67
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $228.40
Upside: -12.43%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.72
Upside: +27.12%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $1.90
Upside: +215.79%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.76
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $160.58
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $38.88
Upside: -35.70%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.12
Upside: -